Clinical Trials Logo
  1. Home
  2. Cocaine Dependence
  3. NCT01906346
  4. Details
NCT01906346 Clinical Trial

Impact of a Non-Drug Choice on Cocaine Reinforcement

Cocaine Dependence Clinical Trial

Official title:
Impact of a Non-Drug Choice on Cocaine Reinforcement

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01906346
Other study ID # R01DA033364-01
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date January 2014
Est. completion date June 2015

Study information
Verified date April 2019
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate self-administration procedures and a non-drug alternative reinforcer, which is hypothesized to reduce the reinforcing effects of cocaine.

Recruitment information / eligibility
Status Completed
Enrollment 9
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 21 Years to 45 Years
Eligibility Inclusion Criteria:

- Cocaine dependence, otherwise healthy

Exclusion Criteria:

- Laboratory results outside of clinically acceptable ranges, history of or current serious physical or psychiatric disease

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Cocaine
Three active doses of cocaine will be made available for self-administration during experimental sessions.
• Placebo
Placebo cocaine will be made available for self-administration during experimental sessions.

Locations
Country Name City State
United States Laboratory of Human Behavioral Pharmacology Lexington Kentucky

Sponsors (1)
Lead Sponsor Collaborator
Joshua A. Lile, Ph.D.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative The reinforcing effects of cocaine were determined using a modified progressive ratio procedure in which subjects made 9 choices between each available cocaine dose and one of three money alternatives. 9 choice trials per cocaine dose level with each trial separated by 30 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04994821 - tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study Phase 2
Completed NCT01601743 - Exercise as a Behavioral Treatment for Cocaine Dependence N/A
Completed NCT01402492 - Cocaine Use Reduction With Buprenorphine Phase 2/Phase 3
Completed NCT01176591 - HBPL Study of the Impact of the NK1 Antagonist Aprepitant Phase 2
Completed NCT00880997 - The Efficacy of Doxazosin for Cocaine Users Phase 1
Completed NCT00566969 - Cocaine Withdrawal and Pharmacotherapy Response N/A
Completed NCT00585520 - Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues Phase 1
Completed NCT00368290 - Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior Phase 2
Completed NCT00385801 - Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence Phase 2
Completed NCT00322309 - Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects Phase 2
Completed NCT00167245 - Topiramate for Alcohol and Cocaine Dependence Phase 2
Completed NCT00842517 - Long Term Maintenance of Drug Abstinence Phase 1
Not yet recruiting NCT05974202 - rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder Phase 2
Completed NCT04411914 - Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid Phase 1
Active, not recruiting NCT03266939 - Rebalancing the Serotonergic System in Cocaine Dependence Phase 1
Completed NCT02563769 - Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study Phase 1
Recruiting NCT06159387 - Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts Phase 4
Terminated NCT02935101 - Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants Phase 2
Completed NCT02018263 - Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans Phase 1
Completed NCT01573273 - Oxytocin in Cocaine Dependence N/A